BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36193313)

  • 1. Medical Data Analysis of CYP1B1 Gene Polymorphism and Clinical Prognosis of Minimally Invasive Surgery for Lung Cancer.
    Han X; Li D; Zhang S
    Biomed Res Int; 2022; 2022():5217625. PubMed ID: 36193313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1B1 Gene Polymorphism Based on Health Monitoring and Nursing Methods after Minimally Invasive Surgery for Lung Cancer.
    Liu C; Liu B; Han X; Zhang Y
    Contrast Media Mol Imaging; 2022; 2022():7042014. PubMed ID: 36128170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.
    Vasile E; Tibaldi C; Leon GL; D'Incecco A; Giovannetti E
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1189-94. PubMed ID: 25504507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
    Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.
    Madeen EP; Löhr CV; You H; Siddens LK; Krueger SK; Dashwood RH; Gonzalez FJ; Baird WM; Ho E; Bramer L; Waters KM; Williams DE
    Mol Carcinog; 2017 Jan; 56(1):163-171. PubMed ID: 26990437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention.
    Li F; Zhang S; Zhang Q; Li J; Zhao S; Gu C
    Biomed Res Int; 2017; 2017():1529564. PubMed ID: 28377924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image.
    Zhang S; Li D; Han X
    Open Life Sci; 2023; 18(1):20220688. PubMed ID: 37791062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.
    Abdul Aziz AA; Md Salleh MS; Yahya MM; Zakaria AD; Ankathil R
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1319-1324. PubMed ID: 33906328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.
    Lao X; Qin X; Peng Q; Chen Z; Lu Y; Liu Y; Li S
    Lung; 2014 Oct; 192(5):739-48. PubMed ID: 24989113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M; Wu Z; Chen J
    Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between CYP1B1 polymorphisms (c.142C > G, c.355G > T, c.1294C > G) and lung cancer risk in Polish smokers.
    Sawrycki P; Domagalski K; Cechowska M; Gąsior M; Jarkiewicz-Tretyn J; Tretyn A
    Future Oncol; 2018 Jul; 14(16):1569-1577. PubMed ID: 29938532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
    Liu JY; Yang Y; Liu ZZ; Xie JJ; Du YP; Wang W
    Mol Genet Genomics; 2015 Apr; 290(2):739-65. PubMed ID: 25475389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
    Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
    Bailey LR; Roodi N; Dupont WD; Parl FF
    Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Precise application of Traditional Chinese Medicine in minimally-invasive techniques].
    Dong FH
    Zhongguo Gu Shang; 2018 Jun; 31(6):493-496. PubMed ID: 29945400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression.
    Kwon YJ; Kwon TU; Shin S; Lee B; Lee H; Park H; Kim D; Moon A; Chun YJ
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166868. PubMed ID: 37661069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
    Chen PF; He XF; Huang GH; Wang W; Qiu ZH
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.